Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-03 Purchase | 2025-10-06 09:12 am | ProMIS Neurosciences Inc. | PMN | Milbury Max A. Principal Accounting Officer | 30,392 | $0.4912 | $14,929 | 45,389 (Direct) | View |
| 2025-06-30 Sale | 2025-07-02 4:15 pm | ProMIS Neurosciences Inc. | PMN | GORDON MICHAEL S 10% Owner | 93,223 | $0 | $0 | 2,123,962 (Indirect Direct) | View |
| 2025-02-10 Purchase | 2025-02-12 5:21 pm | ProMIS Neurosciences Inc. | PMN | Cashman Neil Chief Scientific Officer | 15,000 | $0.973 | $14,595 | 129,921 (Indirect Direct) | View |
| 2024-09-20 Purchase | 2024-09-24 6:56 pm | ProMIS Neurosciences Inc. | PMN | Shafmaster Madge K. Director | 200,000 | $1.2788 | $255,750 | 208,333 (Direct) | View |
| 2024-09-16 Purchase | 2024-09-18 4:15 pm | ProMIS Neurosciences Inc. | PMN | GORDON MICHAEL S 10% Owner | 93,223 | $1.2538 | $116,880 | 2,217,185 (Indirect Direct) | View |
| 2024-08-14 Purchase | 2024-08-16 07:38 am | ProMIS Neurosciences Inc. | PMN | Kirwin Patrick D. Director | 10,000 | $1.2492 | $12,492 | 99,096 (Indirect Direct) | View |
| 2024-07-31 Purchase | 2024-08-02 4:15 pm | ProMIS Neurosciences Inc. | PMN | Title 19 Promis 10% Owner | 465,116 | $0 | $0 | 3,470,977 (Direct) | View |
| 2024-07-31 Purchase | 2024-08-02 4:15 pm | ProMIS Neurosciences Inc. | PMN | GORDON MICHAEL S 10% Owner | 465,116 | $0 | $0 | 3,519,310 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-22 Option Award | 2025-10-24 4:34 pm | N/A 2035-10-22 | ProMIS Neurosciences Inc. | PMN | ABG Management Ltd. Ally Bridge MedAlpha Master Fund L.P. Ally Bridge Group (NY) LLC Yu Fan Alex Slanix Paul 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2025-10-24 4:30 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | Alex Slanix Paul Director | 0 | $0 | 15,748,775 (Indirect) | View |
| 2025-07-25 Exercise | 2025-09-30 4:17 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | Jeremy M. Sclar 2012 Irrevocable Family Trust 10% Owner | 2,093,022 | $0 | 6,849,992 (Direct) | View |
Ownership | 2025-09-30 4:15 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | Jeremy M. Sclar 2012 Irrevocable Family Trust 10% Owner | 0 | $0 | 4,401,570 (Direct) | View |
| 2025-09-22 Option Award | 2025-09-24 08:58 am | N/A 2035-09-22 | ProMIS Neurosciences Inc. | PMN | Warma Neil K Chief Executive Officer | 600,000 | $0 | 600,000 (Direct) | View |
| 2025-09-22 Option Award | 2025-09-24 08:54 am | N/A 2035-09-22 | ProMIS Neurosciences Inc. | PMN | Milbury Max A. Principal Accounting Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2025-09-22 Option Award | 2025-09-24 08:51 am | N/A 2035-09-22 | ProMIS Neurosciences Inc. | PMN | Cashman Neil Chief Scientific Officer | 165,000 | $0 | 165,000 (Direct) | View |
| 2025-09-22 Option Award | 2025-09-24 08:48 am | N/A 2035-09-22 | ProMIS Neurosciences Inc. | PMN | Kaplan Johanne Chief Development Officer | 165,000 | $0 | 165,000 (Direct) | View |
| 2025-09-22 Option Award | 2025-09-24 08:45 am | N/A 2035-09-22 | ProMIS Neurosciences Inc. | PMN | ALTSTIEL LARRY DOUGLAS Chief Medical Officer | 165,000 | $0 | 165,000 (Direct) | View |
| 2025-07-25 Exercise | 2025-09-08 4:10 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | Sclar Jeremy M. 10% Owner | 2,093,022 | $0 | 8,070,718 (Indirect) | View |
Ownership | 2025-08-14 4:40 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | Shaf QIC LLC Shafmaster Jonathan 10% Owner | 0 | $0 | 10,534,639 (Direct) | View |
| 2025-07-25 Exercise(A) | 2025-08-14 4:18 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | Title 19 Promis See Remarks section. | 359,400 | $0 | 1,035,948 (Direct) | View |
| 2025-07-25 Exercise(A) | 2025-08-14 4:17 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | GORDON MICHAEL S See Remarks section. | 359,400 | $0 | 1,035,948 (Indirect) | View |
| 2025-03-13 Other | 2025-08-14 4:15 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | GORDON MICHAEL S See Remarks section. | 48,333 | $0 | 2,483,362 (Indirect) | View |
Ownership | 2025-08-04 5:49 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | ABG Management Ltd. Ally Bridge MedAlpha Master Fund L.P. Ally Bridge Group (NY) LLC Yu Fan 10% Owner | 0 | $0 | 15,748,775 (Indirect) | View |
| 2025-07-25 Exercise | 2025-07-29 8:20 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | GORDON MICHAEL S 10% Owner | 359,400 | $0 | 4,010,077 (Indirect) | View |
| 2025-07-25 Exercise | 2025-07-29 8:18 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | Title 19 Promis 10% Owner | 359,400 | $0 | 4,010,077 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 5:23 pm | N/A 2035-06-12 | ProMIS Neurosciences Inc. | PMN | Mandel-Brehm Josh Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 5:11 pm | N/A 2035-06-12 | ProMIS Neurosciences Inc. | PMN | Kirwin Patrick D. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 5:04 pm | N/A 2035-06-12 | ProMIS Neurosciences Inc. | PMN | Shafmaster Madge K. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:57 pm | N/A 2035-06-12 | ProMIS Neurosciences Inc. | PMN | WYMAN WILLIAM W Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:45 pm | N/A 2035-06-12 | ProMIS Neurosciences Inc. | PMN | Williams Eugene Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 7:04 pm | N/A 2034-11-18 | ProMIS Neurosciences Inc. | PMN | Milbury Max A. Principal Accounting Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 7:03 pm | N/A 2034-11-18 | ProMIS Neurosciences Inc. | PMN | Kaplan Johanne Chief Development Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 7:02 pm | N/A 2034-11-18 | ProMIS Neurosciences Inc. | PMN | Cashman Neil Chief Scientific Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 7:01 pm | N/A 2034-11-18 | ProMIS Neurosciences Inc. | PMN | ALTSTIEL LARRY DOUGLAS Chief Medical Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-10-08 Option Award | 2024-10-10 5:03 pm | N/A 2034-10-08 | ProMIS Neurosciences Inc. | PMN | Warma Neil K Chief Executive Officer | 1,634,460 | $0 | 3,195,194 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-07 6:41 pm | N/A 2034-10-03 | ProMIS Neurosciences Inc. | PMN | WYMAN WILLIAM W Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-07 6:40 pm | N/A 2034-10-03 | ProMIS Neurosciences Inc. | PMN | Williams Eugene Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-07 6:39 pm | N/A 2034-10-03 | ProMIS Neurosciences Inc. | PMN | Shafmaster Madge K. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-07 6:38 pm | N/A 2034-10-03 | ProMIS Neurosciences Inc. | PMN | Mandel-Brehm Josh Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-07 6:36 pm | N/A 2034-10-03 | ProMIS Neurosciences Inc. | PMN | Kirwin Patrick D. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-07-31 Conversion | 2024-08-02 4:15 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | Title 19 Promis 10% Owner | 500,000 | $0 | 3,470,977 (Direct) | View |
| 2024-07-31 Conversion | 2024-08-02 4:15 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | GORDON MICHAEL S 10% Owner | 500,000 | $0 | 3,519,310 (Indirect) | View |